— Why it moved
Why NXTS Stock More Than Quadrupled Today — June 22, 2026
An AI drug-discovery headline met a 426,000-share float: $5 to $23.80 by mid-morning, then a $2.9M offering after the bell sent it back near $7.
What moved NXTS stock
Nexentis is a very small company — a $3.7M cap — whose subsidiary MitoCareX Bio does drug discovery. It announced MitoCareX will work with AI firm Boltz to speed up small-molecule discovery against SLC proteins, targeting cancer and metabolic disease. A real press release with "AI" and "drug discovery" in the same sentence.
The mechanics
The float is about 426K shares. Roughly 60M shares traded — the float turning over well over a hundred times — and any headline moves a structure like that.
NXTS by the numbers
The alert window
Stock Pulse alerted premarket at 8:47 AM at $9.60, already +89% from the $5.08 prior close; the peak $23.80 printed at 10:17 AM — one hour and thirty minutes of window, worth 148%.
How NXTS's move ended
From $23.80 it bled to a $12.88 close, still +34% above the alert. Then after the bell the company priced a $2.9M stock-and-warrant sale at $7.06 and shares fell toward $7 after hours. Everything above the offering price evaporated the same evening — $23.80 at 10:17 AM, roughly $7 by dinner — and the only cash the day actually raised was $2.9M of dilution, priced 45% below the close.
The tell: on a sub-$5M microcap, a monster green day is exactly when the offering lands — the spike is the financing window, and the company is the one selling it.